MedTrace Logo

Risk of Chemotherapy Toxicity in Older Patients With Blood Cancer or Non-small Cell Lung Cancer

NCT05106374 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 182

Last updated 2026-04-13

No results posted yet for this study

Summary

This trial evaluates the risk of chemotherapy toxicity in older patients with blood cancer or non-small cell lung cancer. The purpose of this study is to describe a patient's wellness before and after chemotherapy treatment. This may help researchers better understand patient's ability to tolerate treatment and in the future devise the best treatment for a patient based on their "fitness."

Conditions

  • Hematopoietic and Lymphoid Cell Neoplasm
  • Lung Non-Small Cell Carcinoma

Interventions

PROCEDURE

Biospecimen Collection

Undergo collection of blood and stool samples

PROCEDURE

Cognitive Assessment

Complete thinking test

OTHER

Physical Performance Testing

Complete walking test

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Complete questionnaire

Sponsors & Collaborators

  • Ohio State University Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Ashley E Rosko, MD · Ohio State University Comprehensive Cancer Center

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-04
Primary Completion
2021-09-22
Completion
2021-09-22

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05106374 on ClinicalTrials.gov